Prasol Chemicals Q2 FY27 Results: Revenue surges 38.6% to ₹413 Crore, EBITDA up 86.1%
Prasol Chemicals reported a record Q2 FY27 revenue of ₹413 crore, up 38.6% YoY, with EBITDA at ₹58 crore, up 86.1%. H1 FY27 revenue was ₹846 crore (+37.1% YoY), and EBITDA was ₹148 crore (+106% YoY). The company reiterated its FY27 guidance of ₹1,550-1,650 crore revenue and ₹240-250 crore EBITDA. Phase 1 capex of ₹250-300 crore is progressing, targeting 60,000 tons capacity addition.
The announcement details strong financial performance, record revenue, significant profit growth, and clear future expansion plans, which are material events for investors.
The company reported record quarterly revenue and strong year-on-year growth in revenue, EBITDA, and profit after tax. Management reiterated positive full-year guidance and highlighted progress on expansion plans.
Prasol Chemicals Limited announced its Q2 FY27 results, reporting a record quarterly revenue of ₹413 crore, a year-on-year growth of 38.6%. The company's EBITDA for the quarter stood at ₹58 crore, an increase of 86.1% compared to the previous year. Profit after tax was ₹38 crore, growing by 122.2% year-on-year.
For the first half of FY27 (H1 FY27), revenue from operations reached ₹846 crore, a 37.1% increase year-on-year. EBITDA for H1 FY27 was ₹148 crore, up 106% year-on-year, with an EBITDA margin of 17.5%. Profit after tax for H1 FY27 was ₹99 crore, a significant growth of 138.9% compared to the same period last year.
The company highlighted that H1 FY27 performance has already surpassed the previous year's full-year EBITDA and PAT. This performance excludes an exceptional gain of ₹25 crore and a forex gain of ₹0.92 crore recognized in Q1 FY27, which were due to inventory gains from geopolitical events. The management reiterated their guidance for FY27 revenue between ₹1,550 crore to ₹1,650 crore and EBITDA between ₹240 crore to ₹250 crore, representing a 70% to 75% year-on-year growth.
Prasol Chemicals is also progressing with its Phase 1 capital expenditure program, with approximately ₹75 crore invested so far and an additional ₹75 to ₹100 crore planned before the end of the year. This phase aims to add about 60,000 tons of capacity, increasing the overall installed capacity to 150,000 to 160,000 tons over the next 12-24 months. Phase 2 investments of approximately ₹250-300 crore are also on track, focusing on R&D-led products.
The company is diversifying its raw material sourcing and customer base. Plans are underway to develop a storage facility at Khopoli to optimize logistics and raw material costs. Looking ahead, Prasol Chemicals aims to scale its business to ₹2,800 crore to ₹3,000 crore in the next five years, supported by expansions and new product development.
What to do with a filing like this
Prasol Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Prasol Chemicals Limited. Read the original for the full detail.